Skip to main content

Kashmolah Ghazi's Form 4/A amendment

Amended

Lucira Health, Inc.LHDX · filed Aug 24, 2022

Accession no.
0001209191-22-047309
Filed
Aug 24, 2022
Trade date
Aug 17, 2022
Filing delay
7 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Aug 19, 2022

This filing lists 1 non-derivative transaction. It carries over 1 transaction from the original filing that it did not restate. Open-market sales total $55.9K. It was filed 7 days after the trade.

This amendment restates part of 0001209191-22-046962 (filed Aug 19, 2022). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kashmolah GhaziCIK 0001877741Officer (Ex VP & Chief Quality Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 17, 2022Common StockSSaleDisposed−19,074$2.52F2−$48,066.48180,757Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001209191-22-046962 (filed Aug 19, 2022).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001209191-22-046962
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 18, 2022Common StockSSaleDisposed−3,500$2.25−$7,875177,257Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on September 30, 2021 for 197,240 shares.

F2

This amendment corrects the price of the shares sold, which was inadvertently incorrectly reported on the original Form 4.

Referenced by the price of 1 transaction in Table I.

F3

Includes 2,591 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on February 20, 2022.

Read the full filing on SEC EDGAR (opens in a new tab)